Cell Source Inc (CLCS) Annual Balance Sheets

Annual · GAAP · USD millions
Access CLCS quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Cell Source Inc adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent0.07
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.16
Total Current Assets0.29
Other Assets, Noncurrent0.00
Subscription Receivable0.05
Total Assets0.29
Liabilities
Accounts Payable, Current AC1.89
Accrued Liabilities, Current1.12
Derivative Liability, Current DE0.48
Short-term Debt1.37
Other Liabilities, Current0.00
Deferred Compensation Liability, Current LI1.07
Total Current Liabilities5.92
Total Long-term Debt0.00
Other liabilities, Noncurrent18.82
Warrant Liabilities Current0.31
Convertible Notes Payable Current Net-
Advances Payable Current-
Advances Payable Related Party Current-
Total Liabilities18.82
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock27.60
Retained Earnings / Accumulated Deficit-46.18
Other Equity0.00
Common Stockholder's Equity-18.54
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-18.54
Liabilities & Stockholder's Equity0.29
4 historic quarters locked

Sign in to unlock the full Cell Source Inc balance sheet history.

About Cell Source Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: April 6, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-015359

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.